Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

AstraZeneca PLC ADR (AZN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow AstraZeneca ADR's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
55.56 -1.04    -1.84%
17/09 - Closed. Currency in USD ( Disclaimer )
After Hours
55.54
-0.02
-0.04%
0:41:35 - Real-time Data
  • Volume: 6,990,908
  • Bid/Ask: 55.31 / 55.54
  • Day's Range: 55.13 - 56.35
Type:  Equity
Market:  United States
ISIN:  US0463531089 
CUSIP:  046353108
AstraZeneca ADR 55.56 -1.04 -1.84%
Name Company Industry
   
P/E Ratio TTM 38.78 -
Price to Sales TTM 5.83 5.11
Price to Cash Flow MRQ - -
Price to Free Cash Flow TTM 236.57 -
Price to Book MRQ 9.31 -
Price to Tangible Book MRQ - -
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 76.23% 75.24
Gross Margin 5YA 80.97% 80.89
Operating margin TTM 19.24% -184.72
Operating margin 5YA 16.91% -368.75
Pretax margin TTM 14.87% -229.09
Pretax margin 5YA 11.16% -395.25
Net Profit margin TTM 12.76% -229.09
Net Profit margin 5YA 10.19% -395.25
   
Revenue/Share TTM 11.22 0.25
Basic EPS ANN 1.22 -1.15
Diluted EPS ANN 1.22 -1.15
Book Value/Share MRQ 5.97 -0.02
Tangible Book Value/Share MRQ -6.14 -0.13
Cash/Share MRQ 5.95 0.35
Cash Flow/Share TTM 2.58 -0.56
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 27.02% -
Return on Equity 5YA 17.35% -197.54
Return on Assets TTM 5.64% -65.38
Return on Assets 5YA 3.88% -73.94
Return on Investment TTM 8.22% -86.26
Return on Investment 5YA 5.46% -89.79
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ -27.52% 45.84
EPS(TTM) vs TTM 1 Yr. Ago TTM 75.11% 24.83
5 Year EPS Growth 5YA 1.74% -
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 31% 62.16
Sales (TTM) vs TTM 1 Yr. Ago TTM 14.9% 25.08
5 Year Sales Growth 5YA 1.5% 26.35
5 Year Capital Spending Growth 5YA -1.34% 22.29
   
Quick Ratio MRQ 1.01 2.93
Current Ratio MRQ 1.23 3.05
LT Debt to Equity MRQ 156.93% -
Total Debt to Equity MRQ 175.4% -
Efficiency    
Asset Turnover TTM 0.44 0.29
Inventory Turnover TTM 1.69 1.64
Revenue/Employee TTM 388.02K 181.22K
Net Income/Employee TTM 49.51K -415.15K
Receivable Turnover TTM 5.19 2.67
   
Dividend Yield ANN 2.52% -
Dividend Yield 5 Year Avg. 5YA 3.48% -
Dividend Growth Rate ANN 1.13% -
Payout Ratio TTM 63.43% -
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC ADR
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai May 09, 2021 11:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thanks you AstraZ. Bullish. management services.
Woon soo Lee
Woon soo Lee May 01, 2021 18:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
54 to 64 bullish sentiments again volatility trading
Poh Meng Kong
Poh Meng Kong Feb 25, 2021 22:08
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$68 in 1 month
Nelson T Machin
Nelson T Machin Feb 01, 2021 15:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do you this will grow as EU has approved their Covid vaccine?
Frans Caruana
Frans Caruana Jan 25, 2021 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
will reach 100 in 6 months time
Arek Rusak
Arek Rusak Dec 24, 2020 13:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
bojidar zarev
bojidar zarev Dec 14, 2020 18:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good buy in the long term.
Andre Low
Andre Low Dec 12, 2020 13:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
Nabeel Qabane
Nabeel Qabane Nov 30, 2020 10:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I expect it to reach $ 100 next month
Sandeep Agarwal
Sandeep Agarwal Oct 12, 2020 17:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
for super rich returns
Sandeep Agarwal
Sandeep Agarwal Oct 12, 2020 17:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
u need to hold it for a long term
Alexandros Sfyroeras
Alexandros Sfyroeras Sep 09, 2020 8:40
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Attention , one of the trial subjects had serious implications , follow the news.
Frans Caruana
Frans Caruana Aug 19, 2020 15:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AstraZeneca will be the best vaccine
Peter Lewis
Petelewis1994942 Jul 30, 2020 17:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AZN are months ahead of their rivals - we’ll have a vaccine by October.
aji koo
aji koo Jul 28, 2020 14:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sinovac already had vaccine long before Moderna. But Moderna and Astrazenica have better global distribution...
Wei Foong Wong
Wei Foong Wong Jul 20, 2020 17:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Interesting
Frans Caruana
Frans Caruana Jul 17, 2020 15:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
first Moderna second AstraZeneca to provide vaccine in short time
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email